ROACTEMRA®

Concentrate for solution for infusion, 400mg/20ml
RxActive license

Active substance (INN)

tocilizumab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength400mg/20ml
PackagingUkupno 1 bočica staklena sa 20 ml koncentrata za rastvor za infuziju u kartonskoj kutiji.
ManufacturerF.Hoffmann-La Roche Ltd., Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L04AC07)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateOctober 28, 2022

Analogs in Montenegro

3

Other medicines with the same active substance

ROACTEMRARx
Solution for injection in pre-filled syringe, 162mgF. Hoffmann-La Roche AG
ROACTEMRA®Rx
Concentrate for solution for infusion, 80mg/4mlF.Hoffmann-La Roche Ltd.
ROACTEMRA®Rx
Concentrate for solution for infusion, 200mg/10mlF.Hoffmann-La Roche Ltd.
Source: CInMED register